Unity prices $85M IPO

Unity Biotechnology Inc. (NASDAQ:UBX) raised $85 million late May 2 through the sale of 5 million shares at $17 in an IPO underwritten by Goldman Sachs, Morgan Stanley, Citigroup and Mizuho. The price was at the midpoint of Unity’s proposed range of $16-$18 and values the company at $712.4 million.

Unity began trading on May 3...